NCT03217357View on ClinicalTrials.gov

tDCS, Stress and Risk for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

July 31, 2023

Conditions
Schizophrenia
Interventions
DEVICE

Transcranial stimulation in direct current

tDCS (2mA, 30 minutes with the anode at the left DLPFC and the cathode at the right DLPFC) active or placebo

Trial Locations (1)

69678

Centre Hospitalier Le Vinatier, Bron

All Listed Sponsors
lead

Hôpital le Vinatier

OTHER

NCT03217357 - tDCS, Stress and Risk for Schizophrenia | Biotech Hunter | Biotech Hunter